Eligibility Diabetes Mellitus, Type 2 NCT00393705

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
have type 2 diabetes (world health organization [who] classification).
Descripción

Diabetes Mellitus, Non-Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
are at least 30 years of age and less than 75 years of age.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
have been receiving hypoglycemic treatment with premixed insulin analogue (either with insulin lispro lm or biphasic insulin aspart 30/70) administered twice daily in combination with at least 1500 milligrams (mg) of metformin per day for at least 60 days immediately prior to the study.
Descripción

Hypoglycemic Agents | Premixed insulin Analog Frequency | Insulin Lispro Mixture low | Biphasic insulin aspart | Metformin U/day

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020616
UMLS CUI [2,1]
C2069057
UMLS CUI [2,2]
C0243071
UMLS CUI [2,3]
C0376249
UMLS CUI [3,1]
C0293359
UMLS CUI [3,2]
C0439962
UMLS CUI [3,3]
C0205251
UMLS CUI [4]
C1273270
UMLS CUI [5,1]
C0025598
UMLS CUI [5,2]
C0456683
have a hemoglobin a1c 1.2 to 1.8 times the upper limit of the normal reference range at the local laboratory at visit 1 or
Descripción

Glycosylated haemoglobin increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0239940
have at least 6 of 9 of the postprandial blood glucose values recorded in the period between visit 1 and visit 2 exceeding 180 milligrams per 100 milliliters (mg/dl) (10.0 millimole per liter [mmol/l]).
Descripción

Blood glucose measurement Value Postprandial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392201
UMLS CUI [1,2]
C1522609
UMLS CUI [1,3]
C0376674
have given written informed consent to participate in this study in accordance with local regulations.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
are taking any other oral anti-diabetic medication (oam) not mentioned in inclusion criterion.
Descripción

Antidiabetics Oral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
have a body mass index greater than 40 kilograms per meter squared (kg/m2).
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
have had more than one episode of severe hypoglycemia within 6 months prior to entry into the study.
Descripción

Hypoglycemia Severe Episode Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332189
UMLS CUI [1,4]
C1265611
have congestive heart failure.
Descripción

Congestive heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018802
have an irregular sleep/wake cycle (for example, patients who sleep during the day and work during the night).
Descripción

Sleep-wake cycle disturbance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1833362

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00393705

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
have type 2 diabetes (world health organization [who] classification).
boolean
C0011860 (UMLS CUI [1])
Age
Item
are at least 30 years of age and less than 75 years of age.
boolean
C0001779 (UMLS CUI [1])
Hypoglycemic Agents | Premixed insulin Analog Frequency | Insulin Lispro Mixture low | Biphasic insulin aspart | Metformin U/day
Item
have been receiving hypoglycemic treatment with premixed insulin analogue (either with insulin lispro lm or biphasic insulin aspart 30/70) administered twice daily in combination with at least 1500 milligrams (mg) of metformin per day for at least 60 days immediately prior to the study.
boolean
C0020616 (UMLS CUI [1])
C2069057 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C0376249 (UMLS CUI [2,3])
C0293359 (UMLS CUI [3,1])
C0439962 (UMLS CUI [3,2])
C0205251 (UMLS CUI [3,3])
C1273270 (UMLS CUI [4])
C0025598 (UMLS CUI [5,1])
C0456683 (UMLS CUI [5,2])
Glycosylated haemoglobin increased
Item
have a hemoglobin a1c 1.2 to 1.8 times the upper limit of the normal reference range at the local laboratory at visit 1 or
boolean
C0239940 (UMLS CUI [1])
Blood glucose measurement Value Postprandial
Item
have at least 6 of 9 of the postprandial blood glucose values recorded in the period between visit 1 and visit 2 exceeding 180 milligrams per 100 milliliters (mg/dl) (10.0 millimole per liter [mmol/l]).
boolean
C0392201 (UMLS CUI [1,1])
C1522609 (UMLS CUI [1,2])
C0376674 (UMLS CUI [1,3])
Informed Consent
Item
have given written informed consent to participate in this study in accordance with local regulations.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Antidiabetics Oral
Item
are taking any other oral anti-diabetic medication (oam) not mentioned in inclusion criterion.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Body mass index
Item
have a body mass index greater than 40 kilograms per meter squared (kg/m2).
boolean
C1305855 (UMLS CUI [1])
Hypoglycemia Severe Episode Quantity
Item
have had more than one episode of severe hypoglycemia within 6 months prior to entry into the study.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Congestive heart failure
Item
have congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
Sleep-wake cycle disturbance
Item
have an irregular sleep/wake cycle (for example, patients who sleep during the day and work during the night).
boolean
C1833362 (UMLS CUI [1])